V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20024353 | 20010351 | null | 67.2 | Adjuvant (A) | 2017-09-08 | 2017-09-15 | FEC + DOCETAXEL | 02 | N | 20086066 | FEC + DOCETAXEL |
| 20024354 | 20010352 | 1.62 | 87.5 | Adjuvant (A) | 2014-05-18 | 2014-05-30 | FEC + DOCETAXEL | 02 | N | 20086070 | FEC + DOCETAXEL |
| 20024355 | 20010352 | 1.68 | 59 | Adjuvant (A) | 2015-05-19 | 2015-05-28 | FEC + DOCETAXEL | 2 | null | 20086070 | FEC + DOCETAXEL |
| 20024356 | 20010353 | 1.58 | 114 | Neo-adjuvant (N) | 2016-08-27 | 2016-09-14 | FEC + DOCETAXEL | N | N | 20086080 | FEC + DOCETAXEL |
| 20024357 | 20010354 | 1.56 | 67.1 | Adjuvant (A) | 2013-10-19 | 2013-10-19 | FEC 100 + DOCETAXEL | 02 | N | 20086087 | FEC + DOCETAXEL |
| 20024358 | 20070992 | null | null | Adjuvant (A) | 2017-01-25 | 2017-02-08 | FEC 100 + DOCETAXEL | null | null | 20086090 | FEC + DOCETAXEL |
| 20024359 | 20070992 | 1.6 | 70.4 | Adjuvant (A) | 2017-08-08 | 2017-08-09 | FEC + DOCETAXEL | 02 | N | 20086090 | FEC + DOCETAXEL |
| 20024360 | 20070992 | 1.64 | 109.2 | Adjuvant (A) | 2014-03-03 | 2014-03-07 | FEC + DOCETAXEL | 2 | N | 20086090 | FEC + DOCETAXEL |
| 20024361 | 20010355 | null | null | Neo-adjuvant (N) | 2015-07-27 | 2015-08-20 | FEC + DOCETAXEL | N | N | 20086096 | FEC + DOCETAXEL |
| 20024362 | 20070993 | 1.58 | 102 | Adjuvant (A) | 2014-12-29 | 2014-12-31 | FEC + DOCETAXEL | 02 | N | 20086099 | FEC + DOCETAXEL |
| 20024363 | 20070993 | 1.61 | 103 | Neo-adjuvant (N) | 2017-07-24 | 2017-08-08 | FEC 100 + DOCETAXEL | N | N | 20086099 | FEC + DOCETAXEL |
| 20024364 | 20010356 | 1.11 | 70 | Disease modification (D) | 2014-06-09 | 2014-06-20 | FEC + DOCETAXEL | 2 | N | 20086112 | FEC + DOCETAXEL |
| 20024365 | 20010356 | 1.6 | 130 | Adjuvant (A) | 2017-04-14 | 2017-05-05 | FEC + DOCETAXEL | N | N | 20086112 | FEC + DOCETAXEL |
| 20024366 | 20010357 | 1.72 | 62.2 | Not known (9) | 2017-04-25 | 2017-05-04 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20086114 | FEC + DOCETAXEL |
| 20024367 | 20010357 | 1.55 | 85.7 | Neo-adjuvant (N) | 2017-11-22 | 2017-11-22 | FEC 100 + DOCETAXEL | N | N | 20086114 | FEC + DOCETAXEL |
| 20024368 | 20010358 | 0 | 80 | Adjuvant (A) | 2014-04-23 | 2014-05-15 | FEC + DOCETAXEL | N | null | 20086124 | FEC + DOCETAXEL |
| 20024369 | 20010358 | 1.65 | 60 | Adjuvant (A) | 2013-05-07 | 2013-05-07 | FEC + DOCETAXEL | 2 | Y | 20086124 | FEC + DOCETAXEL |
| 20024370 | 20108463 | 1.69 | 84.7 | Adjuvant (A) | 2017-10-11 | 2017-10-11 | FEC 60 OR 75 + DOCETAXEL | 2 | N | 20086133 | FEC + DOCETAXEL |
| 20024371 | 20010359 | 1.63 | 82.55 | Neo-adjuvant (N) | 2014-08-30 | 2014-09-10 | FEC 100 + DOCETAXEL | N | null | 20086134 | FEC + DOCETAXEL |
| 20024372 | 20070997 | 1.73 | 76.6 | Adjuvant (A) | 2013-09-15 | 2013-09-23 | FEC + DOCETAXEL | 02 | N | 20086135 | FEC + DOCETAXEL |
| 20024373 | 20070997 | 1.73 | 88.2 | Adjuvant (A) | 2015-01-22 | 2015-02-06 | FEC + DOCETAXEL | N | N | 20086135 | FEC + DOCETAXEL |
| 20024374 | 20070997 | 1.65 | null | Neo-adjuvant (N) | 2016-11-14 | 2016-11-28 | FEC + DOCETAXEL | 2 | N | 20086135 | FEC + DOCETAXEL |
| 20024375 | 20070997 | 1.64 | 122 | Adjuvant (A) | 2015-07-27 | 2015-08-24 | FEC + DOCETAXEL | 2 | N | 20086135 | FEC + DOCETAXEL |
| 20024376 | 20070997 | null | null | Adjuvant (A) | 2013-10-08 | 2013-11-05 | FEC + DOCETAXEL | 2 | N | 20086135 | FEC + DOCETAXEL |
| 20024377 | 20010360 | 1.62 | 88.3 | Adjuvant (A) | 2014-02-15 | 2014-03-10 | FEC + DOCETAXEL | 2 | N | 20086148 | FEC + DOCETAXEL |
| 20024378 | 20070998 | 1.73 | 116.6 | Adjuvant (A) | 2016-03-31 | 2016-04-02 | FEC + DOCETAXEL | N | N | 20086149 | FEC + DOCETAXEL |
| 20024379 | 20010361 | 1.72 | 118.6 | Adjuvant (A) | 2017-06-22 | 2017-06-28 | FEC + DOCETAXEL | 02 | N | 20086152 | FEC + DOCETAXEL |
| 20024380 | 20070999 | null | 100.6 | Adjuvant (A) | 2016-12-24 | 2017-01-14 | FEC 100 + DOCETAXEL | 1 | null | 20086155 | FEC + DOCETAXEL |
| 20024381 | 20010362 | 1.6 | null | Adjuvant (A) | 2016-04-01 | 2016-04-11 | FEC 100 + DOCETAXEL | N | null | 20086156 | FEC + DOCETAXEL |
| 20024382 | 20010362 | 1.64 | 61.1 | Adjuvant (A) | 2017-02-01 | 2017-02-02 | FEC + DOCETAXEL | 02 | N | 20086156 | FEC + DOCETAXEL |
| 20024383 | 20108465 | null | 78.85 | Adjuvant (A) | 2016-12-13 | 2016-12-24 | FEC + DOCETAXEL | 02 | N | 20086162 | FEC + DOCETAXEL |
| 20024384 | 20010363 | 1.64 | 66 | Neo-adjuvant (N) | 2016-03-21 | 2016-03-21 | FEC + DOCETAXEL | 02 | N | 20086170 | FEC + DOCETAXEL |
| 20024385 | 20010364 | 1.76 | 71.2 | Curative (C) | 2015-12-17 | 2015-12-18 | FEC + DOCETAXEL | 02 | N | 20086171 | FEC + DOCETAXEL |
| 20024386 | 20010365 | 1.6 | 87 | Neo-adjuvant (N) | 2017-06-05 | 2017-06-14 | FEC 100 + DOCETAXEL | 02 | null | 20086177 | FEC + DOCETAXEL |
| 20024394 | 20010367 | 1.66 | null | Adjuvant (A) | 2017-02-02 | 2017-03-22 | FEC + DOCETAXEL | N | N | 20086198 | FEC + DOCETAXEL |
| 20024395 | 20071002 | null | 103.4 | Neo-adjuvant (N) | 2016-12-09 | 2016-12-22 | FEC 100 + DOCETAXEL | N | N | 20086199 | FEC + DOCETAXEL |
| 20024396 | 20071002 | 1.74 | 74.35 | Adjuvant (A) | 2016-07-05 | 2016-07-16 | FEC + DOCETAXEL | 02 | N | 20086199 | FEC + DOCETAXEL |
| 20024397 | 20010368 | null | 69.6 | Adjuvant (A) | 2013-08-29 | 2013-09-06 | FEC 60 OR 75 + DOCETAXEL | N | N | 20086202 | FEC + DOCETAXEL |
| 20024398 | 20010368 | 1.61 | 74.1 | Adjuvant (A) | 2016-03-09 | 2016-03-30 | FEC 100 + DOCETAXEL | N | null | 20086202 | FEC + DOCETAXEL |
| 20024399 | 20010369 | 1.64 | 117.4 | Curative (C) | 2016-08-05 | 2016-08-05 | FEC + DOCETAXEL | 02 | N | 20086207 | FEC + DOCETAXEL |
| 20024400 | 20010370 | 1.71 | 81 | Adjuvant (A) | 2014-07-09 | 2014-07-09 | FEC + DOCETAXEL | 02 | null | 20086208 | FEC + DOCETAXEL |
| 20024401 | 20010370 | 1.54 | 78.7 | Neo-adjuvant (N) | null | 2017-07-22 | FEC + DOCETAXEL | N | N | 20086208 | FEC + DOCETAXEL |
| 20024402 | 20010371 | 1.64 | 104 | Not known (9) | 2013-06-27 | 2013-07-04 | FEC 100 + DOCETAXEL | N | N | 20086215 | FEC + DOCETAXEL |
| 20024403 | 20010371 | 1.62 | 65.6 | Neo-adjuvant (N) | null | 2016-06-28 | FEC 100 + DOCETAXEL | N | N | 20086215 | FEC + DOCETAXEL |
| 20024404 | 20010372 | 1.6 | 57.1 | Curative (C) | 2016-12-09 | 2016-12-24 | FEC + DOCETAXEL | N | N | 20086228 | FEC + DOCETAXEL |
| 20024405 | 20010373 | 1.67 | 76.9 | Adjuvant (A) | 2015-08-09 | 2015-08-11 | FEC + DOCETAXEL | 2 | N | 20086231 | FEC + DOCETAXEL |
| 20024406 | 20010373 | 1.55 | 46 | Curative (C) | 2016-06-28 | 2016-07-19 | FEC + DOCETAXEL | N | N | 20086231 | FEC + DOCETAXEL |
| 20024407 | 20010373 | 1.73 | 80.3 | Neo-adjuvant (N) | 2017-06-13 | 2017-07-02 | FEC + DOCETAXEL | 2 | N | 20086231 | FEC + DOCETAXEL |
| 20024408 | 20127754 | 1.6 | 57.3 | Neo-adjuvant (N) | 2016-08-03 | 2016-08-12 | FEC + DOCETAXEL | N | N | 20086246 | FEC + DOCETAXEL |
| 20024409 | 20127754 | null | null | Adjuvant (A) | 2016-03-11 | 2016-03-11 | FEC + DOCETAXEL | 99 | null | 20086246 | FEC + DOCETAXEL |